Bristol-Myers Squibb CompanyBMYNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank79
3Y CAGR-8.9%
5Y CAGR+24.2%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-8.9%/yr
vs +29.7%/yr prior
5Y CAGR
+24.2%/yr
Recent deceleration
Acceleration
-38.6pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.54B | +359.1% |
| 2024 | $3.17B | -83.6% |
| 2023 | $19.37B | +0.8% |
| 2022 | $19.22B | -4.5% |
| 2021 | $20.12B | +308.2% |
| 2020 | $4.93B | -33.2% |
| 2019 | $7.38B | +8.7% |
| 2018 | $6.79B | +11.0% |
| 2017 | $6.12B | -5.4% |
| 2016 | $6.46B | - |